EMEA-002626-PIP01-19

Key facts

Active substance
loxoprofen (sodium hydrate)
Therapeutic area
Pain
Decision number
P/0417/2019
PIP number
EMEA-002626-PIP01-19
Pharmaceutical form(s)
Medicated plaster
Condition(s) / indication(s)
Treatment of pain
Route(s) of administration
Topical use
Contact for public enquiries
Lead Chemical Co. Ltd

E-mail: a-numa@lead-chemical.co.jp
Tel.  +81 764645710

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating